New pill tested to protect kidneys from silent disease
NCT ID NCT05016323
Summary
This study tested whether a new capsule called HR19042 could safely reduce protein loss in the urine for people with IgA nephropathy, a kidney disease. It compared the capsule to a placebo (dummy pill) in 316 adults with confirmed disease. The main goal was to see which dose worked best to control the disease and protect kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NanFang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
Conditions
Explore the condition pages connected to this study.